Galantamine protects against synaptic, axonal, and vision deficits in experimental neurotrauma

Our goal was to investigate the neuroprotective effects of galantamine in a mouse model of blast-induced indirect traumatic optic neuropathy (bITON). Galantamine is an FDA-approved acetylcholinesterase inhibitor used to treat mild-moderate Alzheimer’s disease. We exposed one eye of an anesthetized m...

Descripción completa

Detalles Bibliográficos
Autores principales: Naguib, Sarah, Bernardo-Colón, Alexandra, Cencer, Caroline, Gandra, Neha, Rex, Tonia S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769189/
https://www.ncbi.nlm.nih.gov/pubmed/31778813
http://dx.doi.org/10.1016/j.nbd.2019.104695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769189/
https://www.ncbi.nlm.nih.gov/pubmed/31778813
http://dx.doi.org/10.1016/j.nbd.2019.104695

Ejemplares similares